Inside Aesthetics Ep 82 Kybella/Belkyra & Everything About Fat Dissolving Injections | Dr Sachin Shridharani
Episode 82 hosts Dr Sachin Shridharani (Plastic Surgeon from Manhattan, New York)
Sachin is also a leading cosmetic injector who's research interests have allowed him to develop his own novel techniques.
In this episode we explore Belkyra (branded as Kybella in the USA) - a fat dissolving injectable product. Belkyra is licensed for treating the double chin but we discuss the 'off label' areas that can be treated, the best candidates for the treatment, the rare pitfalls and more!
0:00 Introduction 1:03 MeetDr Sachin Shridharani 3:19 Practice and Clinic Background 5:16 Starting a Practice in Manhattan 9:44 Growth After COVID Lockdowns 11:56 Surge in Surgical Demand 14:01 Patient Behavior and Spending Trends 16:30 Financial Stability and Treatment Decisions 18:16 Training and Career Path 23:53 Building Luxurgery Practice 27:02 Research and Clinical Trials 30:22 New Devices and Injectables Pipeline 33:44 Focus on Fat Dissolving Treatments 37:39 What Is Kybella and How It Works 41:39 Development and FDA Approval History 45:36 Early Adoption and Learning Curve 48:05 Managing Patient Expectations 51:43 Treatment Timeline and Patience 57:32 Treatment Process Explained 1:01:04 Safety and Tissue Effects 1:03:30 Injection Technique and Grid Use 1:07:48 Adoption Challenges and Cost Concerns 1:12:19 Controlling Fat Reduction Outcomes 1:16:00 Treating Laterally and Jawline Contouring 1:19:56 Nerve Injury Risk and Recovery 1:22:22 CoolSculpting Versus Kybella 1:25:07 Choosing the Right Treatment Method 1:27:43 Skin Tightening and Inflammatory Response 1:30:37 Pain Management and Local Anesthetic 1:33:59 Improving Patient Experience 1:36:53 Injection Techniques and Cannula Use 1:39:25 Off Label Treatment Areas 1:42:10 Common Treatment Sites Beyond Chin 1:44:30 Areas That Respond Best to Treatment 1:48:40 Safety Considerations by Body Area 1:53:30 Differences From Older Fat Dissolving Products 1:55:45 Managing Complications and Adverse Events 2:00:30 Injection Errors and Prevention 2:03:05 Handling Serious Complications 2:05:40 Clinical Responsibility and Training 2:10:55 Final Advice for Practitioners 2:13:30 Best Practice and Risk Management 2:18:00 Industry Perspective and Future Use 2:20:15 Wrap Up and Closing